ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 25 filers reported holding ARYA SCIENCES ACQU CORP IV in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $398,759 | +34.3% | 36,752 | +31.7% | 0.04% | +50.0% |
Q2 2023 | $296,962 | +3.1% | 27,910 | 0.0% | 0.03% | +21.7% |
Q1 2023 | $288,031 | -13.0% | 27,910 | -14.9% | 0.02% | +35.3% |
Q4 2022 | $331,058 | -1.2% | 32,778 | -3.0% | 0.02% | +54.5% |
Q3 2022 | $335,000 | – | 33,784 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |